The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...
SEOUL: KT&G, South Korea’s largest tobacco company, announces it has signed a memorandum of understanding (MoU) with American tobacco giant Altria, laying the groundwork for strategic collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback